healthcare-investing
(2)
Kevin Xu
Kevin Xu is the Chairman and CEO of ClinChoice, a global full-service contract research organization (CRO) with more than 30 years of history, roughly 4,000 staff, and operations across 15+ countries. He arrived in the corner office from the investor's side of the table: for over 15 years he was a Managing Director at Goldman Sachs, where he built and ran the firm's Asia-Pacific Healthcare and Life Sciences investing practice, leading deals across biotech, pharma, medtech, CROs/CDMOs and digital health. Trained in neuroscience and clinical psychology before finance, he is an outspoken advocate for destigmatizing mental illness and an unlikely wake-surfer.
Giovanni Ahern
Giovanni Ahern is an Investing Partner at Andreessen Horowitz (a16z), one of Silicon Valley's most influential venture capital firms, where he focuses on growth-stage investments. A dual-degree MIT graduate in Mathematics and Computer Science with Economics, Ahern built his investment acumen through roles at Blackstone, Houlihan Lokey, and three years as a Private Equity Associate at Bain Capital specializing in healthcare and technology. Joining a16z in September 2025, he brings a quantitative rigor and cross-sector perspective to backing the next generation of market-defining technology companies.